Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
221.1 USD | -0.22% | -3.07% | -6.35% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.35% | 11.42B | |
+35.90% | 50.93B | |
-0.41% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+12.11% | 26.02B | |
-22.01% | 18.9B | |
+7.37% | 13.21B | |
+24.45% | 12.17B | |
+28.95% | 12.16B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Charles River Laboratories International Q1 Non-GAAP Earnings Rise, Revenue Fall; Maintains Full Year 2024 Earnings Guidance